4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Imerys S.A. (NK) operates in the Specialty Chemicals industry and is headquartered in Paris, France with about 12,300 employees. Its market capitalization is roughly €2 billion. In the fiscal year ended 2025-12-31, NK reported €3.4B in revenue and (€409M) in net income.
Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €3.4B | €3.6B | €3.8B | €4.3B | — |
| Gross Profit | €2.3B | €2.4B | €2.4B | €2.8B | — |
| Operating Income (EBIT) | €191M | €250M | €252M | €396M | — |
| Net Income | (€409M) | (€95M) | €51M | €237M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | — | €832M |
| Net Income | — | €48M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€123M) | (€116M) | (€327M) | (€138M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €6.2B | €6.7B | €7.2B | €7.9B | — |
| Total Liabilities | €3.5B | €3.4B | €4.0B | €4.5B | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NK viewer.
About TickerBase · Data methodology & sources · Privacy · Terms